AI summary by TwinMind
Former Pharma Rep on Health Insurance Corruption and Pharmacies
PowerfulJRE
14m 1s
Insurance Model Limitations
- Academia has tons of studies on alternative treatments not adopted due to insurance model constraints
- Doctors only use tools in their "tool belt" - if not covered by insurance, they don't discuss it
- Lack of time to explore options outside insurance coverage
- Large language models could provide patient education without waiting for doctor visits
- Team of academics at fingertips for proactive analysis
Four P's of Future Healthcare + Privacy Concerns
- Predictive, proactive, personalized healthcare model discussed
- Private - critical 4th P
- Data must NOT be in hands of insurance companies
- Gary Breco example: worked for big insurance companies assessing all-cause mortality risk
- Insurance companies would use wearable data to:
- Limit care coverage
- Kick patients off plans
- Predict chronic disease onset
- Charge more when they can monetize
- Drop coverage when unprofitable
- Large language models as "sword" - beneficial in right hands, dangerous in wrong hands
Pharmacy Benefit Managers (PBMs) System
- Middlemen between insurance companies and Big Pharma
- Originally created to negotiate pharmaceutical prices for average Americans
- Government couldn't decipher which drugs to cover
- Within one decade: insurance companies acquired PBMs
- Within second decade: PBMs began negotiating rebates to themselves, not discounts to patients
- $244 million fraud in Ohio state example
- "Margins made in the mystery" - more confusing = more profits
Insurance Company Profit Levers
- Raise co-pays, deductibles, out-of-pocket expenses
- Drive down wholesale drug prices while marking up coverage
- Tier pricing system manipulation:
- Tier 1 drugs marketed as "best" but actually most profitable
- Tier 4 drugs less profitable due to lesser rebates
- Pricing NOT based on what's best for patient
Insulin Pricing Case Study
- Average insulin price: $381 (Senate Finance Committee finding)
- Pharmaceutical company received: less than $40
- Remaining $340+ stayed with PBM
- PBMs making billions annually deciding coverage, co-pays, deductibles
GLP-1 Weight Loss Drug Example
- Appears on insurance as tier 4 with high price tag
- Listed price: $1,300
- Insurance never pays $1,300 (pays fraction)
- Patient charged 50% co-pay = $500
- Insurance profits from rebate AND patient overpayment
Pharmacy Acquisition Tactics
- Insurance companies bought mail-order pharmacies
- Blue Cross Blue Shield owed speaker's pharmacy over $1 million for one month
- Refused payment claiming missing co-pay/deductible collection
- 3-month delay for auditor while small pharmacy struggles
- Insurance companies then acquire struggling pharmacies
- "Gobbled up lifeblood of America" - eliminated small pharmacies
MS Treatment Cost Manipulation
- Friend's MS treatment: $14,000/month listed price
- Speaker has 26 employees across organizations
- Insurance claimed they paid $144,000/month for drug
- Used this to justify raising rates for all employees
- Never actually paid $14,000 due to back-end rebate negotiations
- System is profit-driven, not patient outcome-driven
Systemic Healthcare Problems
- Cannot operate in insurance ecosystem and provide quality care
- Everything controlled and dictated by insurance
- Most people lack understanding/awareness
- No push to fix, regulate, or analyze problems
- Many clinicians unaware of PBM system
Disease State Monetization
- "If I can monetize your diabetes, why would I cure or prevent it?"
- Insurance executives switch jobs every 3 years
- Long-term complications become someone else's problem
- Focus on quarterly earnings, not long-term patient outcomes
Orthopedic Surgery Example
- New joint more expensive but astronomically better 5-year outcomes
- Hospital CEO response: "I don't give a f* what happens 5 years out"**
- Only cares about 90-day performance metrics
- Cheaper joint preferred if lasts minimum 90 days
- Accountability only exists for first 90 days post-surgery
Primary Care Consolidation
- Independent primary care physicians largely eliminated
- Employed by hospital systems and major conglomerates
- Hospitals buy primary practices to control patient population
- Control referral patterns to profit from disease states
- Example: Primary care → oncology referrals within same profit system
Genetic Testing Gaps
- Methyl folate test rarely run by primary care
- Test reveals genetic predispositions
- Epigenetics: daily choices impact gene expression
- No conversations about hormone levels, sun exposure, proper nutrition in 30s
- Push toward chronic disease through symptom-treating prescriptions
Oncology Profit Model
- 65% of oncologist income comes from chemotherapy markup
- Financial incentive to use expensive treatments
- Insurance companies sometimes try to incentivize generics when no rebate available
- Clinicians operating within system constraints, not necessarily to blame
- Playing by rules set before them
Russell Brand Quote
- "If we make things about profit and quarterly earnings and big business and not patient outcomes, don't be shocked when we get phenomenal quarterly earnings and piss poor patient outcomes"
